Supported by numerous publications and clinical trials, our ExPERT™ family of electroporation instruments deliver robust performance, efficiency, flexibility, and scalability to propel promising new therapies from concept to clinic.
The development of novel and efficacious therapies is dependent on a strong technological platform to bring your ideas from bench to bedside. The ability to quickly optimize experimental or manufacturing parameters help enable the rapid and cost-effective development of therapies to use safely in clinical trials.
Learn more or download or select case studies.
Any Cell.
Electroporation/non-viral approach with broad cell compatibility
Any Molecule.
Transfect any molecule with the MaxCyte® ExPERT® platform
Established regulatory path
- cGMP Compliant
- Master File with US FDA and Health Canada
Which instrument is right for you?
- Seamless scalability from 50,000 to 20,000,000,000 cells means no re-optimization upon scaling up.
- Superior transfection efficiency and/or viability compared to competing platforms for most applications.
- One universal electroporation buffer for all cell types and applications.
- On-demand user training, technical support, and scientific support so you have the help you need when you need it.
- cGMP compliance and FDA Master File for expedited regulatory approval when translating for clinical us.
